CURE Epilepsy CEO Beth Dean explains how the organization funds research, why it remains “patient-focused” in its mission, and what areas of epilepsy research offer the most promise for finding cures.
Today on Seizing Life, we speak with epilepsy researcher, educator, and patient Dr. Steve White. Dr. White has been involved in the field of epilepsy research for over 40 years, is a former CURE Epilepsy grant-recipient and a current member of the organization’s Scientific Advisory Board. He is also an epilepsy patient, having experienced his first seizure in 2010.
We revisit just a few of the amazing conversations from 2020. From growing up with epilepsy to an Army Captain’s battle with PTE, examining the epilepsy/mental health connection and finding hope in genetic research, Seizing Life spoke with a number of insightful and inspiring guests this year – even if we had to do it at a distance.
In the finale of our 4-part series exploring the drug development process, we get the patient perspective on participating in clinical trials.
In the third of our 4-part series exploring the drug development process, we share what patients should know about participating in clinical trials.
In the second of our 4-part series exploring the drug development process, we take a deep dive into the clinical trial phases.
In the first of a 4-part series about new drug development and clinical trial participation, we explain the complex process starting with basic research through pre-clinical trials.
Mike Coburn of Research!America shares insights on the near- and long-term impacts of the COVID-19 pandemic on epilepsy research and the research community at large.
Discover how NINDS funds epilepsy research and fosters collaboration towards cures from Program Director Dr. Vicky Whittemore.
CURE Taking Flight Grantee Dr. Gemma Carvill explains how genetic research discoveries in the lab can lead to precision care in the doctor’s office.